Lastest from Businesswire

Subscribe to Lastest from Businesswire feed Lastest from Businesswire
Business Wire - The global leader in news distribution
Updated: 1 min 15 sec ago

Boston Millennia Partners Intends to Vote Against Proposed Merger of SomaLogic With Standard BioTools

Sun, 12/31/2023 - 14:46
BOSTON--(BUSINESS WIRE)--Boston Millennia Partners (“Boston Millennia”), a significant shareholder of SomaLogic (the “Company”) (Nasdaq: SLGC) today announced that it intends to vote against the Company’s planned merger (the “Merger”) with Standard BioTools Inc. (Nasdaq: LAB).

DG NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Dollar General Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – DG

Sun, 12/31/2023 - 11:46
NEW YORK--(BUSINESS WIRE)---- $DG #DG--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dollar General Corporation (NYSE: DG) between May 28, 2020 and August 30, 2023, both dates inclusive (the “Class Period”), of the January 26, 2024 lead plaintiff deadline. SO WHAT: If you purchased Dollar General common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH

CHPT NOTICE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages ChargePoint Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CHPT

Sun, 12/31/2023 - 11:46
NEW YORK--(BUSINESS WIRE)---- $CHPT #CHPT--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ChargePoint Holdings, Inc. (NYSE: CHPT) between June 1, 2023 and November 16, 2023, both dates inclusive (the “Class Period”), of the important January 29, 2024 lead plaintiff deadline. SO WHAT: If you purchased ChargePoint securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem

BCLI FINAL DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm

Sun, 12/31/2023 - 08:46
NEW YORK--(BUSINESS WIRE)---- $BCLI #BCLI--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) between August 15, 2022 and September 27, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline in the securities class action commenced by the Firm. SO WHAT: If you purchased Brainstorm Cell securities during the Class Period you may be entitled to compensation without paym

BARCLAYS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Barclays PLC Investors to Secure Counsel Before Important January 2 Deadline in Securities Class Action Commenced by the Firm – BCS, BCLYF

Sat, 12/30/2023 - 14:46
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Barclays PLC (NYSE: BCS) (OTC: BCLYF) between July 22, 2019 and October 12, 2023, both dates inclusive (the “Class Period”), of the important January 2, 2024 lead plaintiff deadline in the securities class action commenced by the Firm. SO WHAT: If you purchased Barclays securities during the Class Period you may be entitled to compensation without payment of any out of pock

BARCLAYS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Barclays PLC and Encourages Investors to Contact the Firm

Fri, 12/29/2023 - 23:46
NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Barclays securities between July 22, 2019 and October 12, 2023, both dates inclusive (the “Class Period”). Invest

SOLAREDGE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against SolarEdge Technologies, Inc. and Encourages Investors to Contact the Firm

Fri, 12/29/2023 - 23:46
NEW YORK--(BUSINESS WIRE)-- #A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against SolarEdge Technologies, Inc. (“SolarEdge” or the “Company”) (NASDAQ: SEDG) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired SolarEdge securities between February 22, 2022, and October 19, 2023, both dates inclusive (th

BRAINSTORM CELL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Brainstorm Cell Therapeutics Inc. and Encourages Investors to Contact the Firm

Fri, 12/29/2023 - 23:46
NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Brainstorm Cell Therapeutics Inc. (“Brainstorm Cell” or the “Company”) (NASDAQ: BCLI) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Brainstorm Cell securities between August 15, 2022 and September 27, 2023, both dat

OUTLOOK DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Outlook Therapeutics, Inc. and Encourages Investors to Contact the Firm

Fri, 12/29/2023 - 23:46
NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased or otherwise acquired Outlook securities between August 3, 2021 and August 29, 2023, both dates inclusive (the “Class Period”).

POSaBIT Closes Non-Brokered Unit Offering to Fund Convertible Unsecured Note Maturity

Fri, 12/29/2023 - 20:45
TORONTO--(BUSINESS WIRE)--POSaBIT Systems Corporation (CSE: PBIT, OTC: POSAF) (the "Company" or "POSaBIT"), a leading provider of payments infrastructure in the cannabis industry, is pleased to announce that, further to its previous press release dated December 21, 2023, it has closed a non-brokered private placement of 3,107,142 units of the Company (the "Units"), at a price of CAD$0.28 per Unit, for aggregate gross proceeds of approximately CAD$870,000 or USD$650,000 (the "Offering") to fund

Prospector Capital Corp. No Longer Listed on Nasdaq Following Completion of Business Combination

Fri, 12/29/2023 - 20:45
LA JOLLA, Calif.--(BUSINESS WIRE)--Prospector Capital Corp. (the “Company”) announced today that on December 18, 2023, it received a letter from the listing qualifications department staff of The Nasdaq Stock Market (“Nasdaq”) notifying the Company that it would be de-listed from the Nasdaq Capital Market for failure to maintain a minimum Market Value of Listed Securities at or above the minimum of $35 million required for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listin

Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures

Fri, 12/29/2023 - 20:45
NEW YORK--(BUSINESS WIRE)--Madryn Asset Management, LP (collectively with its affiliates, “Madryn” or “we”), a holder of approximately 4.2% of the outstanding common stock of SomaLogic, Inc. (“SomaLogic” or the “Company”) (Nasdaq: SLGC), today issued the following statement regarding the proposed merger (the “Proposed Merger” or the “Transaction”) with Standard BioTools Inc. (“Standard BioTools”) (Nasdaq: LAB). We would like to thank the many shareholders and stakeholders who have engaged in a

BARCLAYS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Barclays PLC - BCS

Fri, 12/29/2023 - 20:45
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 2, 2024 to file lead plaintiff applications in a securities class action lawsuit against Barclays PLC (NYSE: BCS), if they purchased the Company’s securities between July 22, 2019 and October 12, 2023, inclusive (the “Class Period”). This action is pending in the United States District Court for the Centra

Modiv Industrial Declares Distribution of GIPR Common Shares

Fri, 12/29/2023 - 20:45
RENO, Nev.--(BUSINESS WIRE)--Modiv Industrial, Inc. (“Modiv Industrial,” “Modiv” or the “Company”) (NYSE:MDV), the only public REIT exclusively focused on acquiring industrial manufacturing real estate properties, today announced the declaration of a stock distribution of Generation Income Properties, Inc. (NASDAQ: GIPR), common stock to the stockholders of Modiv Industrial. On December 29, 2023, Modiv Industrial received GIPR’s notice that on January 31, 2024, it will redeem the GIPR Series A

Conveyer Policy APIs Bring Federal Rules into Businesses’ Data Ecosystems

Fri, 12/29/2023 - 20:45
HACKENSACK, N.J.--(BUSINESS WIRE)--Conveyer, a revolutionary AI platform transforming the way that businesses operationalize data, today announced the launch of its Curated Data Repository, a powerful Data as a Service (DaaS) platform that organizes, summarizes, and filters large and complex datasets to enable seamless knowledge discovery. The first dataset accessible via the Curated Data Repository is Conveyer’s U.S. Policy Data solution, a unique, constantly growing resource comprised of more

Pages